<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04039074</url>
  </required_header>
  <id_info>
    <org_study_id>Relax</org_study_id>
    <nct_id>NCT04039074</nct_id>
  </id_info>
  <brief_title>Effects of Yoga and Relaxation on Stress and Quality of Life</brief_title>
  <official_title>Effects of Yoga and Relaxation on Stress and Quality of Life - a Three-armed Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to measure the effects of three stress reduction methods on patients
      with stress and stress associated complaints.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 29, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stress questionnaire (Cohen Perceived Stress Scale, CPSS)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Change from Baseline in the CPSS, range from 0 to 4 in each item. Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 &amp; 4 = 0) to the positively stated items and then summing across all scale items while higher values meaning a higher grade of perceived stress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medical Outcomes Study Short Form Quality of Life (MOS SF-36)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-100, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-42, lower score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zerssen symptom list (B-LR and B-LR')</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 20-80, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>MET minutes represent the amount of energy expended carrying out physical activity. To get a continuous variable score from the IPAQ (MET minutes a week) we will consider walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maslach Burnout Inventory (MBI)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-96, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness (Freiburger Fragebogen zur Achtsamkeit, FFA)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-56, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspects of Spirituality (ASP)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-112, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Regulation</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 16-96, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Assessment of Interoceptive Awareness (MAIA)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-160, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trauma symptoms (Posttraumatic Checklist, PCL-5)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-80, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mysticism Scale Short Form</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing full scale, range 0-32, higher score meaning a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Analog Scales</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Assessing stress, back pain, headache, shoulder/neck tension, sleep quality, exhaustion, nervousness, digestive complaints, mood on 0-11 points each.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expectation questions</measure>
    <time_frame>Date of inclusion (baseline)</time_frame>
    <description>For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation questions</measure>
    <time_frame>After 12 weeks, after 24 weeks</time_frame>
    <description>For intervention 1, intervention 2 and intervention 3 on a 6-point likert scale from 1 (very strong) to 6 (nothing at all)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bio-electrical Impedance Analysis (BIA)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Estimation of the body composition via bio-electrical impedance analysis (muscle mass in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary Behaviour assessed by Food Frequency Questionaire (Gesundheit Erwachsener in Deutschland, DEGS)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Quantitative description of nutritional habits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication intake</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Name of medication and dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability (HRV)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Faros 180 (chest)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sociodemographic Measurements</measure>
    <time_frame>Date of inclusion (baseline)</time_frame>
    <description>Age, gender, education level, household income, employment status, marital status, language spoken, complete family history, current and previous illness and co-morbidities, and current medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral questions: alcohol consumption</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Number of alcoholic beverages on average per week in the last month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral questions: relaxation</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Relaxation behavior on average per week in the last month in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral questions: cigarettes</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>Number of cigarettes on average per week in the last month in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrodermal Activity (Galvanic Skin Response)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Volume Pulse</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration Rate</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interbeat Interval (IBI)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate (HR)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Faros 180 (chest), Biovotion Everion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin Temperature</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Oxygenization</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight (kg)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
    <description>24h measuring by Biovotion Everion device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (kg/m2)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference (cm)</measure>
    <time_frame>Date of inclusion (baseline), after 12 weeks, after 24 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Qualitative interviews in focus groups interviews</measure>
    <time_frame>12 weeks after inclusion</time_frame>
    <description>Qualitative assessment will be carried out in 45-minute focus group interviews in 12 (randomized selected) patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Stress, Psychological</condition>
  <arm_group>
    <arm_group_label>Integrative Yoga</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 12-week &quot;Integrative Yoga&quot; intervention which has meditative and psycho-educational components corresponding to traditional yoga practice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iyengar yoga</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A 12-week established, predominantly body-oriented yoga intervention (Iyengar yoga).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A 12-week mindfulness intervention designed for the healthy handling of stress.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Integrative Yoga</intervention_name>
    <description>A 12-week &quot;Integrative Yoga&quot; intervention which has meditative and psycho-educational components corresponding to traditional yoga practice.</description>
    <arm_group_label>Integrative Yoga</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Iyengar Yoga</intervention_name>
    <description>A 12-week established, predominantly body-oriented yoga intervention (Iyengar yoga).</description>
    <arm_group_label>Iyengar yoga</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness</intervention_name>
    <description>A 12-week mindfulness intervention designed for the healthy handling of stress.</description>
    <arm_group_label>Mindfulness</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - stress with at least 4 of 10 points on the Numeric Analogue Scale (NAS) at least 1 month
        and at least 3 of the following 8 stress symptoms: sleep disorder, inappetence or increased
        appetite, shoulder neck tension/back pain, tension headache, concentration disorder,
        exhaustion, nervousness/irritability, stress-associated digestive problems

        Exclusion Criteria:

          -  serious acute or chronic diseases

          -  pregnancy or lactation

          -  known serious mental illness

          -  immobility or restriction for gymnastics exercises due to orthopaedic, neurological or
             other medical cause

          -  participation in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Michalsen, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite - Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miriam Roesner</last_name>
    <phone>+49 30 80505 682</phone>
    <email>m.roesner@immanuel.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus</name>
      <address>
        <city>Berlin</city>
        <zip>14109</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Rösner, Study nurse</last_name>
      <phone>00493080505682</phone>
      <email>m.roesner@immanuel.de</email>
    </contact>
    <investigator>
      <last_name>Andreas Michalsen, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>July 28, 2019</study_first_submitted>
  <study_first_submitted_qc>July 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Andreas Michalsen</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Yoga</keyword>
  <keyword>Meditation</keyword>
  <keyword>Progressive muscle relaxation</keyword>
  <keyword>Stress</keyword>
  <keyword>Education</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

